期刊文献+

先天性马蹄内翻足动物模型胚胎后肢(芽)评分系统的建立 被引量:4

Scoring system of hind-limb development in a murine model
原文传递
导出
摘要 目的建立一套稳定的评分系统,提供客观的观察指标来确认胚胎早期先天性马蹄内翻足(congenital clubfoot,CCF),进行序列胚胎研究。方法60只Wistar大白鼠,体重220250g,随机分成实验组和对照组各6组。从怀孕第10天起,将维甲酸玉米油混悬液经胃管单次注入,以建立马蹄内翻足动物模型,分别在受孕第13、14、15、16、17、18天取出胎鼠的后肢芽并经过一系列处理。应用评分系统对胎鼠进行评分。结果经评分系统得出的动物模型CCF发病率为80.9%,经评分系统矫正后的CCF发病率较既往报道高。在实验组和对照组之间的软骨分化存在显著差异。结论应用评分系统可以有效地筛选出CCF,可以对筛选出的CCF胚胎在关键的研究时间窗口进行系列研究,有效地解决了长期困扰CCF研究难以深入的瓶颈问题。 Objective Quantification of the severity of congenital clubfoot is essential for its research and treatment. Up to date, no scoring system is available for hind limb bud development. In this study,a scoring system was established based on a murine model. Methods Sixty female Wistar rats weighing 220-250 g were randomized into the six control groups and six experimental groups. Vaginal sperm plug detection day was considered to be day 0 of gestation. Hind limb buds from fetuses of E13, 14,15,16,17 and 18 days were removed and processed. Results Morphogenetic differentiation changes were detected in the experimental groups. According the new scoring system, clubfoot-like deformity was present in 80. 9% of the experimental fetuses. We were able to quantify the extent morphogenetic differentiation of the hind limb accordingly. Conclusions Congenital clubfoot deformities begin at early developmental stage and become exaggerated as the fetuses mature. The scoring system can quantify the extent of congenital clubfoot deformity and facilitate its management.
出处 《中华小儿外科杂志》 CSCD 北大核心 2009年第6期397-400,共4页 Chinese Journal of Pediatric Surgery
基金 广东省自然科学基金资助(7008219) 广东省科技计划项目资助(2006B35901008)
关键词 马蹄内翻足 维甲酸 肢芽 Equinovarus Tretinoin Clim bud
  • 相关文献

参考文献3

二级参考文献29

  • 1周海涛,孙开来,李增钢,赵彦艳,李岭,吉士俊,马瑞雪,尚超,李春义,富伟能.全反式维甲酸诱导大鼠胚胎马蹄内翻足模型[J].中国公共卫生,2004,20(4):413-415. 被引量:6
  • 2李增刚,孙开来.视黄类受体与视黄酸致畸作用关系[J].遗传,2004,26(5):735-738. 被引量:4
  • 3周海涛,孙开来,富伟能,吉士俊,赵彦艳,金春莲.马蹄内翻足胎大鼠胫骨后肌组织的蛋白质组学分析[J].中国药理学与毒理学杂志,2005,19(4):289-295. 被引量:6
  • 4吉士俊,陈秋,张成普,周永德,刘卫东.先天性马蹄内翻足病因学研究[J].中华小儿外科杂志,1996,17(2):108-111. 被引量:30
  • 5Sun C,Cai M,Meadows RP,et al.NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP.J Biol Chem,2000,275:33777-33781.
  • 6Miranda MB,Dyer KF,Grandis JR,et al.Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation:a requirement for Bcl-XL and XIAP in the prolonged survival of monocytic cells.Leukemia,2003,17:390-400.
  • 7Holcik M,Gibson H,Korneluk RG.XIAP:apoptotic brake and promising therapeutic target.Apoptosis,2001,6:253-261.
  • 8Kaur S,Wang F,Venkatraman M,et al.X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor-beta 1 (TGF-beta 1) through ubiquitin-mediated proteosomal degradation of the TGF-beta activated kinase 1 (TAK1).J Biol Chem,2005,280:38599-38608.
  • 9Komori T.Functions of BMPs,Runx 2,and osterix in the development of bone and cartilage.Nippon Rinsho,2005,63:1671-1617.
  • 10Yamaguchi K,Nagai S,Ninomiya-Tsuji J,et al.XIAP,a cellular member of the inhibitor of apoptosis protein family,links the receptors to TAB1-TAK1 in the BMP signaling pathway.EMBO J,1999,18:179-187.

共引文献30

同被引文献46

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部